| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Nitisinone | SC-0735; SYN-118; NTBC | Approved | Swedish Orphan Biovitrum Ag | Orfadin, Nityr | United States | Tyrosinemias | Swedish Orphan Biovitrum Ag | 2002-01-18 | Alkaptonuria; Blindness; Tyrosinemias; Albinism | Details |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



